BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Vote in favor of the wide open action that revives your brain and soul! - 2Wisconsin archaeologists identify 16 ancient canoes in a prehistoric lake 'parking lot'
- 3The Best Competitors of the 21st Hundred years
- 45 Side interests That Work on Psychological wellness
- 5Tech Patterns: Contraptions That Will Shape What's in store
- Earth’s magnetic field protects life on Earth from radiation, but it can move, and the magnetic poles can even flip
- The Response to Self-improvement: Embracing a Development Outlook
- Rachael Ray is navigating grief this holiday season. She doesn't have time for 'negative energy' on the internet.
- Canada cancels its 1st moon rover: 'It's hopefully not a lost cause'
- Reporter's notebook: Inside the IDF’s ‘Hamas Village,’ and how Israel is rewriting urban warfare
- Struggling to keep your New Year's resolutions? Here's how to keep yourself on track
- The most effective method to Involve Handshakes for Compromise and Compromise
- Best Amusement Park in Asia: Which One Is a Must-Visit
- Figure out How to Keep up with and Clean Your Brilliant Bed for Ideal Execution
